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Studies of the Structure of the N-Terminal domain from the Y4
receptor - a G protein-coupled receptor - and its Interaction with
hormones from the NPY family
Abstract
Binding of peptide hormones to G protein-coupled receptors is believed to be mediated through
formation of contacts of the ligands with residues of the extracellular loops of family 1 GPCRs. Here we
have investigated whether additional binding sites exist within the N-terminal domain, as studied in the
form of binding of peptides from the neuropeptide Y (NPY) family to the N terminus of the Y4 receptor
(N-Y4). The N-terminal domain of the Y4 receptor has been expressed in isotopically enriched form and
studied by solution NMR spectroscopy. The peptide is unstructured in solution, whereas a
micelle-associated helical segment is formed in the presence of dodecylphosphocholine (DPC) or
sodium dodecylsulfate (SDS). As measured by surface plasmon resonance (SPR) spectroscopy, N-Y4
binds with approximately 50 M affinity to the pancreatic polypeptide (PP), a high-affinity ligand to the
Y4 receptor, whereas binding to neuropeptide Y (NPY) and peptide YY (PYY) is much weaker.
Residues critical for binding in PP and in N-Y4 have been identified by site-directed mutagenesis. The
data indicate that electrostatic interactions dominate and that this interaction is mediated by acidic ligand
and basic receptor residues. Residues of N-Y4 are likely to contribute to the binding of PP, and in
addition might possibly also help to transfer the hormone from the membrane-bound state into the
receptor binding pocket.
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Studies of the structure of the N-terminal domain 
from the Y4 receptor, a G-protein coupled receptor, 
and its interaction with hormones from the NPY 
family 
 
2.1 Introduction 
 
Neuropeptide Y receptors, so-called Y receptors, are members of the rhodopsin-
like G-protein coupled receptor (GPCR) family 1b. The neurohormones neuropeptide 
Y (NPY), peptide YY (PYY) and the pancreatic polypeptide (PP) target a 
heterologous population of at least five different receptor subtypes Y1, Y2, Y4, Y5 
and y61. Their physiological role in the regulation of blood pressure, memory 
retention, food uptake and seizure has been demonstrated. Y4 receptors for example 
have been shown to play a pivotal role in cardiac function, glucose metabolism in 
chronic pancreatitis patients, and mediation of intestinal absorption of electrolytes and 
water.2 NPY and PYY posses a similar pharmacology displaying nanomolar affinities 
for all receptor subtypes3, whereas PP binds with very high affinity and selectivity to 
the Y4 receptor.4 
Little structural information is available for GPCRs. In fact, bovine rhodopsin for 
a long time was the only GPCR for which experimental coordinates at atomic 
resolution have been published 5 until very recently a structure for the b-adrenergic 
receptor appeared.6; 7 The data of rhodopsin confirmed the arrangement of the 7 
transmembrane (TM) bundle postulated based on the lower-resolution cryo-EM data 
8, but also revealed the non-anticipated presence of a short anti-parallel beta-sheet in 
the N-terminal domain. In contrast, the N-terminal domain of the b-adrenergic 
receptor was shown to be disordered.6  
The N-terminal domains of other GPCRs (sub)families are known to play 
important roles in ligand binding. All the hormone receptors from GPCR family 2 
contain a conserved region in the N-terminal domain, which is responsible for ligand 
binding.9 The N termini from family 3 GPCRs are the largest among all GPCRs, 
comprising usually more than 500 amino acids.9 Grafting and mutagenesis studies 
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have demonstrated conserved serine and threonine residues in these domains are 
directly involved in ligand binding.10 Surprisingly, the expressed N terminus alone 
can bind the ligand with affinity similar to the one from the full-length receptor.11  
In contrast, the N-terminal domains from family 1 GPCRs have received little 
attention, most likely because of their short length, usually less than 70 amino acids. 
However, recent studies have suggested a pivotal role of N termini from GPCRs of 
this class in ligand recognition and binding12; 13; 14. Furthermore, mutagenesis data 
highlight the prominent role of charged residues for ligand binding15; 16. Koller 
demonstrated that the N terminus of the calcitonin-like receptor is not only essential 
for binding to the ligands but also presents a determinant for ligand specificity.17 The 
35 amino-terminal residues of CCR2, expressed as a membrane-bound fusion protein, 
bind to its ligand with an affinity similar to that of the intact, wild-type receptor, 
indicating that the N terminus is sufficient for ligand binding in that case.18 Based on 
the mutagenesis data on the N terminus of CX3C receptor and previous studies, Chen 
has proposed a two-step binding model, which comprises ligand binding followed by 
receptor activation. Therein, the residues located in the N-terminal domain play 
distinct roles during the different processes19. 
Complementary to the biological work described above GPCR fragments have 
been also studied using NMR. For example, Pervushin investigated the N-terminal 
domain of bacteriorhodopsin, a protein that is structurally highly related to GPCRs, in 
SDS micelles20, and Ulfers studied the extracellular domain of the neurokinin-1 
receptor in DPC micelles21. Riek presented a high-quality 3D NMR structure of the 
extracellular domain of CRF-R2β in complex with the peptide antagonist astressin22. 
The group of Yeagle has determined conformational preferences for peptides 
corresponding to the cytosolic loops23, the 6th TM helix24 and the N-terminus23 of 
rhodopsin and Pellegrini studied the cytosolic domain25 and the extracellular loops26; 
27 of the PTH1 receptor in the presence of DPC micelles. Furthermore, we recently 
determined the conformation of a polypeptide corresponding to the 7th TM helix of 
the yeast Ste2p receptor extended by 40 residues from the cytosolic tail 28 when 
integrated into DPC micelles. 
In this work we focus on structural studies of the isolated 41 residue N terminus of 
the Y4 receptor, a family 1b GPCR that is targeted by members of the NPY family. 
The location of this segment in the context of the entire human Y4 receptor is shown 
in snake plot in Fig. S1(see Supp. Mat.). In addition, we investigate possible 
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interactions with the hormones both qualitatively and quantitatively. By limiting the 
system of the study to just the N-terminal domain and with the help of various 
biophysical methods we were able to develop a rather detailed picture, that would 
presently be difficult to achieve using the entire receptor.  Moreover, we report on the 
synthesis of the difficult to express N-terminal domain suggesting a generally useful 
method to produce these polypeptides in isotopically-labelled form. The structure of 
N-Y4 and its topology in the presence of DPC or SDS micelles was elucidated by 
high-resolution NMR techniques. While unstructured in solution, in the presence of 
micelles a hydrophobic segment associates with the micelle and folds into a a-helix. 
Chemical shift mapping revealed potential interaction sites between PP and N-Y4. 
SPR techniques quantified the strength of this interaction. Mutagenesis studies 
identified residues of PP that are likely to be important for binding N-Y4. The data 
indicate that the isolated N- Y4 is capable of weakly binding to PP, and that much of 
the binding affinity is due to electrostatic interactions. To simulate the receptor milieu 
the carboxyl terminus of N-Y4 was additionally conjugated to a C12 fatty amino 
alcohol (dodecylphospho-ethanolamine) chain thereby mimicking its conjugation to 
the first TM helix in the entire receptor. In this lipopeptide the structure of the N-Y4 
was not significantly affected. The study shows that PP associates to the flexible, 
central segment of N-Y4 and we speculate that transient binding to the N-terminal 
domain may facilitate transferring PP from the membrane-bound state into the 
receptor binding pocket.  
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2.2 Results 
2.2.1 Recombinant Production of N-Y4 
 
The N terminus of the Y4 receptor comprises 41 residues and is highly water-
soluble. However, attempts to express it in form of a soluble ubiquitin fusion in E. 
coli resulted in unspecific fragmentation. To circumvent this problem, the N-Y4 was 
expressed as a fusion to the highly insoluble protein ketosteroidisomerase (KSI), 
which resulted in accumulation of the fusion protein in inclusion bodies. A TEV 
protease cleavage site was introduced to facilitate removal of the fusion partner.29; 30 
The sequence recognized by the TEV protease is ENLYFQ with Q as the P1’ residue. 
To achieve the natural peptide sequence after cleavage, the P1’ residue was replaced 
with the first residue from the target sequence (here it is Met)31, and an additional 
GSGSGS linker was inserted to prevent steric hindrance during cleavage.  
A problem of the chosen strategy was that the fusion protein must be solubilized 
in detergent that is compatible with the active protease. After extensive detergent 
screening, we observed that the ionic detergent sarcosyl solubilizes the fusion protein 
while preserving TEV protease activity to some extent. As shown in Fig. 1 cleavage 
efficiency is around 40% allowing recovery of about 2mg of 15N-labeled N-Y4 from 
1L of culture.  
 
 
Figure 1: SDS-PAGE of the cleavage product of the ketosteroid isomerase- N-Y4 fusion after 
cleavage with the TEV protease. A size marker is shown on the left. Note that N-Y4 due to its 
small size cannot be detected on the gel. 
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2.2.2 The Structure of N-Y4 
Although the size of the N-terminal domain is rather small, reduced chemical shift 
dispersion due to the fact that the peptide in water is largely unstructured complicated 
its analysis. Nevertheless, using 3D 15N-resolved NOESY and TOCSY spectra it was 
possible to assign the 15N,1H-correlation map. Furthermore, no NOE crosspeaks 
between amide protons could be detected. Recording a second set of 2D and 3D 
spectra in the presence of DPC micelles resulted in large chemical shift changes in 
some parts of the sequence (see Fig.2).  
 
 
Figure 2: Differences of backbone amide 1H (top) and 15N (bottom) chemical shifts of N-Y4 in the 
presence and absence of DPC micelles.  
 
Moreover, sequential NOEs between amide protons as well as HaHb (i,i+3) 
contacts usually only observed in helices were seen (see Supp. Mat.). A structure 
calculation using restraints derived from the NOESY spectra revealed the presence of 
a helical stretch encompassing residues 5 to 10 (shown in Fig.3). 
To verify formation of stable secondary structure 15N{1H}-NOE spectra were 
recorded both in the absence as well as in the presence of DPC. The heteronuclear 
NOE sensibly reports on the rigidity of the backbone at the corresponding residue, 
with negative values characteristic of flexible parts and values larger than 0.5 usually 
observed in elements of secondary structure. The 15N{1H}-NOE data show dramatic 
differences in aqueous medium and DPC. Residues 1-27 have values <0 for N-Y4 in 
water whereas all of these residues have 15N{1H}-NOE values >0 in the DPC bound 
state (Fig. 4). Strikingly, residues 5-10 have a 15N{1H}-NOE >0.5. Interestingly, a 
 6 
segment encompassing residues 26 to 33 is rather rigid, in both environments. We 
observed  
 
 
Figure 3: Comparison of the structures calculated for N-Y4 in the presence of DPC (left) or SDS 
(right) micelles (only bonds from backbone atoms are depicted). Bonds from disordered residues 
16-41 are not shown for clarity. 
 
sequential amide proton contacts in that region for almost all residues, but the 
corresponding Ha Hb (i,i+3) contacts were generally missing. When comparing 
chemical shifts of amide protons in the two environments the largest differences were 
observed in that segment that obviously becomes structured in the presence of the 
micelle, indicating the presence of a nascent helix in that part. To conclude, the N 
terminus is largely unstructured in the absence of a membrane whereas a short helical 
stretch comprising a hydrophobic segment in the N terminus of the sequence is 
formed in presence of DPC micelles.  
 
 
Figure 4: Values of the 15N{1H}-NOE of N-Y4 in plain buffer (black spheres) and in the 
presence of DPC micelles (red diamonds). Data were recorded on 1mM samples at pH=5.6, 
310K, at 700 MHz proton frequency. 
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Considering the importance of electrostatic interactions for ligand binding and to 
investigate whether (stabilizing) interactions of the N-terminal domain with the 
membrane head groups might be formed we further initiated structural studies of N-
Y4 in the presence of SDS micelles, a negatively charged membrane mimetic. Values 
of the 15N{1H}-NOE rapidly revealed that N-Y4 was not significantly better 
structured in this environment. Moreover, a structure calculation again revealed the 
presence of an a-helix spanning the region between residues 3 to 10. NOEs between 
sequential amide protons were seen at the C-terminal end from residue 36 on, but the 
corresponding Ha,Hb (i,i+3) contacts were missing, indicating that a transient helix is 
formed towards the C terminus. Interestingly, this part in the full-length receptor is 
connected to the first TM. In general, sequential amide proton contacts in the more 
flexible regions were stronger when compared to the data recorded in the presence of 
DPC suggesting that the negatively charged surface promotes the formation of 
transient helical structures to a slightly larger extent. This fact is particularly well-
documented in the heteronuclear NOEs for residues of the segment encompassing 
residues 19-25, which is much less flexible in the presence of SDS micelles (see Fig. 
S8).  But in general the structural features of the peptide in DPC and SDS were 
similar (for more data on the SDS-recorded sample see the Supp. Mat.) 
 
2.2.3 Topology of Membrane-Association 
 
The proximity of protons of the N-terminal domain to the micelle surface was 
probed by using micelle-integrating spin labels.  The paramagnetic moiety of 5-doxyl 
stearic acid was shown to reside in the headgroup region32 Consistent with the 
assumption that structuring of the N-terminal segment is induced by binding to the 
micelle, signals from the amide moieties within that segment experienced the largest 
signal reduction (see Fig. S9). The spin-label data indicate that the N-terminal helix is 
tightly associated with the micelle, whereas the central segment makes more transient 
contacts. Motions in that region are likely limited at both ends by the adjacent 
hydrophobic residues 24-30 and the membrane-anchored N-terminal helix.  It was 
previously demonstrated that attenuations in helical regions of surface-associated 
peptides follow periodic patterns.33; 34 The present data indicate that the helical region 
is not bound in a parallel fashion to the micelle-surface. Moreover, from the lack of a 
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clear pattern in the attenuation we conclude that this part is also not anchored in a 
precisely defined mode.  
We have additionally tested whether binding of bPP to N-Y4 could possibly 
trigger dissociation of the N terminus from the micelle. However, no decrease of 
signal reduction from the spinlabel could be detected upon addition of bPP to micelle-
bound N-Y4, indicating that N-Y4-micelle contacts are largely unchanged, even in the 
presence of a large excess of bPP (concentration ratio of N-Y4 to bPP 1:30) (data not 
shown). This indicates that bPP cannot initiate detachment of N-Y4 from the micelle 
surface, supporting the view that the contact site between bPP and Y-4 is not located 
in the helical segment of Y-4 and hence does not interfere with micelle association. 
 
2.2.4 Immobilizing the N Terminus on the Membrane 
 
In the native Y4 receptor the segment that has been studied in this work is 
connected to the first TM helix. In order to address whether anchoring of N-Y4 at its 
C-terminal end to the membrane influences the structure or the binding properties of 
the N-terminal domain a lipopeptide was chemically synthesized, in which receptor 
residues 1-41 were covalently linked at their C-terminus to dodecylethanolamine to 
provide stable anchoring of the lipopeptide in the micelles. The lipopeptide was 
prepared using standard amino-acid coupling chemistry, purified, and could be tightly 
integrated into the DPC micelles. A superposition of the NOESY spectra of N-Y4 and 
the lipopeptide in the presence of DPC micelles revealed that chemical shift 
differences are exclusively observed in vicinity of the lipid attachment site. Moreover, 
cross peaks between amide protons occur at identical positions, indicating that the 
secondary structure of both the peptides is highly similar. To conclude, anchoring of 
N-Y4 onto the micelle does not influence its secondary structure, which more likely is 
determined by partitioning of residues of the hydrophobic Leu-rich segment into the 
membrane. As evident from Fig. 3 the carboxyl terminal segment of N-Y4 possesses 
high flexibility both in the presence and in the absence of DPC micelles. Whether this 
will also be true when the C-terminus is linked to the first TM helix is presently under 
investigation.   
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2.2.5 Interaction between N-Y4 and Neuropeptides from the NPY Family 
Possible interactions between peptides from the NPY family and N-Y4 were 
probed both by chemical shift mapping as well as by surface plasmon resonance 
(SPR). PP represents a natural ligand for the Y4 receptor, and accordingly the binding 
affinity between N-Y4 and PP was measured under physiological conditions (10mM 
HEPES pH 7.4, 150mM NaCl) both in absence and presence of DPC micelles. The 
data for chemical shift mapping were acquired using 15N-labeled NPY,PP or PYY and 
unlabeled N-Y4 as well as using 15N-labeled NY-4 and unlabelled neuropeptides. The 
shift mapping experiments revealed significant shift changes in the PP-N-Y4 
interaction studies (see Fig. 5). Large changes in the PP/N-Y4 system occurred close 
to positions that were later on shown to be sensitive to replacement by Ala residues 
(vide infra). In addition, the shift changes involving PYY and NPY are generally 
much smaller compared to those with PP (data not shown). 
 
 
Figure 5: Differences of chemical shifts of amide proton and nitrogen frequencies of backbone 
resonances of bPP in the presence and absence of N-Y4 (Dd= d(bPP(N-Y4)) – d (bPP) (left) and 
of N-Y4 upon addition of bPP (right). Values are computed according to Ddc(1H,15N) = SQR 
[(Dd1H)2 + 0.2*(Dd15N)2]. Positions at which mutations were performed (E4K, Q19R and E23A in 
PP and K13A, R20A and K23A in N-Y4) are indicated by grey bars. 
 
The strength of the interaction of PP with N-Y4 was quantified by SPR in absence 
of detergent. Therein, the N-terminally biotinylated neuropeptides were immobilized 
on a Streptavidin-coated chip, and the cells were flushed with solutions of N-Y4 (see 
Fig. 6). The KD derived from both kinetic and steady-state analysis was 50mM for 
bPP, whereas binding affinity for NPY and PYY was too low to be measured with 
this technique (> 1mM).  
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Figure 6: Left: SPR sensogram of the interaction of N-Y4 with bPP for various concentrations of 
N-Y4 (in the range of 5 to 100 µM). Right: Plot of the steady-state value of the sensograms vs. the 
concentration of N-Y4, used for extraction of the dissociation constant KD. 
 
Measuring binding of membrane-immobilized peptides towards N-Y4 by SPR 
methods is technically very challenging, and hence KD in the presence of micelles 
were measured using NMR data by fitting changes in chemical shifts as derived from 
peak positions of the neuropeptides in [15N,1H]-HSQC spectra in the  presence of 
varying amounts of  N-Y4. For micelle-bound bPP the KD to N-Y4 is approx. 600mM 
and experiments, in which varying amounts of PP were added to N-Y4, resulted in a 
very similar value. Apparently, the KD in the presence of micelles is much lower than 
in the absence of micelles. This is not really surprising since it presents the affinity of 
the ligand towards the N-terminal domain in the presence of competing membrane 
binding, and hence reflects the difference in binding affinity between the two sites. 
NPY and PYY possess 80% sequence identity between each other35, while PP 
only shares about 50% homology to each of them. All these neuropeptides display a 
remarkable separation of charges along the sequence: The positively charged residues 
occur in the C-terminal half of PP from almost all organisms sequenced so far (see 
Table 1). In order to identify residues that may contribute significantly to the different 
pharmacological profiles of NPY/PYY and PP at the Y4 receptor we have aligned the 
sequences. Particular attention was paid to charged or aromatic residues that are 
known to be generally involved in GPCR-ligand interactions. The N termini of all Y 
receptor subtypes are generally negatively charged with the exception of N-Y4 that 
contains a net positive charge (see Table 1). Considering the high number of positive 
charges in N-Y4 and negative charges in the N-terminal half of bPP electrostatic 
interactions are likely to be responsible for binding, and such forces are also expected 
to result in the observed rather weak binding affinities.  
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Table 1. Sequence alignment of the principal members of the NPY family and of the N-terminal 
domains from the various Y receptor subtypes. Positions in bPP and hN-Y4 replaced by other 
amino acids in this work have been underlined. 
 
pNPY: YPSKPDNPGE DAPAEDMARY YSALRHYINL ITRQRY-NH2 
pPYY: YPAKPEAPGE DASPEELSRY YASLRHYLNL VTRQRY-NH2 
bPP :   APLEPEYPGD NATPEQMAQY AAELRRYINM LTRPRY-NH2 
          *  *  *    *  *    *    ** * *   ** **   
hN-Y1: MNSTLFSQVE NHSVHSNFSE KNAQLLAFEN DDCHLPLAMI 
hN-Y2: MGPIGAEADE NQTVEEMKVE QYGPQTTPRG ELVPDPEPEL IDSTKLIEVQ 
hN-Y4: MNTSHLLALL LPKSPQGENR SKPLGTPYNF SEHCQDSVDV M 
hN-Y5: MSFYSKQDYN MDLELDEYYN KTLATENNTA ATRNSDFPVW 
DDYKSSVDDL Q 
 
As depicted in Table 1 common acidic residues in PP, NPY and PYY are located 
at positions 6, 10 and 15. PP mutants E4K, Q19R and E23A were produced by site-
directed mutagenesis in order to probe for the importance of differently charged 
residues between PP and NPY/PYY at these positions. The dissociation constant for 
Q19R-bPP was only marginally reduced to 89mM, whereas binding of E4K-bPP and 
E23A-bPP to N-Y4 was too weak to be detected by SPR. The data indicate that it is 
the additional negative charges in PP and their distribution along the sequence that 
may be important for its different binding affinities at the N-Y4.  
In order to verify that electrostatic interactions between acidic residues of PP and 
basic residues in the N-Y4 are contributing to binding, the K13A, R20A and K22A 
mutants of the N-terminal domain of the Y4 receptor were synthesized and 
investigated by SPR. In all of these mutants binding to bPP was significantly reduced. 
The measured values for the KD were 249 mM (R20A), 281mM (K22A) and for 
K13A binding was too weak to be detected by SPR. The combination of the 
mutagenesis studies performed on acidic residues of PP and basic residues of N-Y4 
suggests that the binding affinity between the two is determined by electrostatic 
interactions to a large extent. In this work we have abstained from experiments in 
which residues in PP and N-Y4 were charged-reversed simultaneously because in 
those mutants electrostatics are likely to be perturbed in both molecules, and hence it 
is questionable whether activity could have been rescued. 
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2.3 Discussion 
 
The mechanism for recognition of ligands by their receptors is of prime biological 
and pharmaceutical interest. Due to the enormous problems in expression, purification 
and reconstitution of sufficient amounts of GPCRs, little progress has been made in 
structural studies over the last decade, and so far bovine rhodopsin and the b-
adrenergic receptor are the only GPCRs for which high-resolution X-ray data are 
published. In this work we have attempted to investigate the structure of the isolated 
N-terminal extracellular domain of the Y4 receptor, a GPCR targeted by hormones of 
the NPY family, and which binds to PP with very high affinity. Moreover, we 
determined the interaction with PP and the other members of the NPY family and 
investigated the role of specific residues for binding.  
Structural studies of GPCR fragments could possibly suffer from the fact that 
interactions with the remainder of the receptor are missing that may be structurally 
relevant. As to the present analysis the N-terminal domain of the published crystal 
structure of b-adrenergic receptor was largely unstructured, and did not display 
interactions with other parts of this GPCR, in particular not with the extracellular 
loops. This supports our contention that the conformations of the N-terminal domains 
of a GPCR are not significantly determined by interactions with the remainder of the 
receptor. Such a study also allows us to directly define contributions of residues from 
the N-terminus of the Y-4 receptor to ligand binding.  
While the N-terminal domain of Y4 is largely unfolded in solution upon binding 
to zwitterionic (DPC) or negatively charged (SDS) micelles, a hydrophobic segment 
comprising residues 5 to 10 forms a rather stable a-helix, and the nascent helix 
encompassing residues 26-35 is slightly rigidified. The central region and the C-
terminal hexapeptide remain largely unstructured. The helical segment comprising 
residues 5 to 10 is entirely formed by hydrophobic residues. The structural data and 
the internal backbone dynamics of N-Y4 in the presence of zwitterionic (DPC) and 
anionic (SDS) headgroups display only minor differences indicating that the 
conformation does not depend on specific features of the surrounding lipids. Both 
formation of secondary structure and association with the membrane seem to be 
controlled by the hydrophobicity of the residues and their partitioning into the 
membrane36  Strongly favorable values for the latter are encountered only in the a-
 13 
helical stretch and in the segment between residues 24 to 30, exactly those regions for 
which the spin-label data indicate proximity to the water-membrane interface. Spin-
label, dynamics and structural data of Y-4 reveal the central segment to be rather 
flexible. The segregation of N-Y4 into structured and flexible regions is very similar 
in the presence of zitterionic or negatively charged lipid headgroups. As a 
consequence of these features it appears likely that this domain may perform larger 
movements on the membrane surface, and hence could possibly undergo various 
structural or translational transitions in order to interact with the extracellular loops or 
with the membrane-bound ligands. We like to mention at this point that the N-
terminal domain of the b-adrenergic receptor was also disordered in the crystal 
structure from Kobilka6; 7, and that the N-terminal domains from many other class-1 
GPCRs are predicted to be largely unfolded. This indicates that the fact that N-Y4 is 
mainly flexible is likely not an artifact due to the usage of a receptor fragment but 
rather reflects a commonly encountered feature of these receptors. 
We have recently proposed that binding of hormones from the NPY family to 
their receptors is preceded by association of the ligands to the membrane. According 
to ideas originally proposed by Kezdy and Kaiser37; 38 and later developed into the 
membrane-compartment model by Schwyzer39; 40 binding to the membrane reduces 
the search for the receptor to two dimensions, increases the concentration in the 
vicinity of the receptor and possibly induces conformations that facilitate receptor 
binding. Structural studies of porcine (p) NPY33 and PYY41 and of bovine (b) PP42 
bound to membrane-mimicking dodecylphosphocholine (DPC) micelles revealed 
large structural changes occurring during membrane association.43 From this picture 
the important question arises how the hormones enter the binding pocket, once the 
membrane-bound species has laterally diffused along the membrane into the 
proximity of the receptor. The seven-helix bundle provides a rather rigid scaffold that 
does not allow large rearrangements of the extracellular loops in order to facilitate 
diffusion of the membrane-bound ligand into the binding pocket. Therefore the 
hormones need to detach from the membrane. Data for binding affinities of the 
hormones towards phospholipid membranes determined by us using SPR indicate that 
membrane binding is only moderate.41 Any part of the receptor that possesses higher 
affinity to the peptides than the membrane does, and which could be accessed by a 
ligand that is in proximity to the membrane surface, may help to guide the ligand into 
the binding pocket. The N-terminal domains of the Y receptors are 40-50 amino acid 
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residue long polypeptide segments located in the extracellular space44, and hence 
present potential interaction sites for the ligands. This work now indicates that at least 
for PP transient association with the N-Y4 may be part of the cascade of events 
leading to receptor activation. It should be emphasized here that transient binding to 
the N-terminal domain does not exclude larger structural changes in the 
conformations of loop residues that may occur later on when the ligands have diffused 
into the genuine receptor binding pockets. Such changes or rotations of the TM 
helices are believed to be important for receptor activation, and the above-described 
events merely serve to guide the ligand from the membrane-bound state into the 
binding pocket. 
Binding of PP to the N-terminal domain of the Y4 receptor, which is often 
referred to as the PP-preferring receptor, is moderate with a dissociation constant of 
about 50mM. NPY and PYY, two hormones from the NPY family with very similar 
pharmacology and high sequence similarity with respect to each other, do not bind to 
this domain. Sequence alignments reveal that PP overall is more negatively charged 
than NPY or PYY, particularly in the N-terminal region, and our studies show that 
replacement of E4 or E23 in PP largely abolished binding to N-Y4. Furthermore, 
introduction of Arg into position 19 lead to only marginal changes in binding affinity. 
The N-Y4 domain, in contrast to the N-terminal domains from all other receptor 
subtypes, contains a comparably large number of positively charged residues (K13, 
R20 and K22), which are also relatively close to each other in sequence. Their 
replacement by Ala as described above leads to significant losses in binding affinity. 
To conclude taking the importance of acidic PP and basic N-Y4 residues into account 
we speculate that electrostatic interactions between PP and N-Y4 are crucial for this 
interaction. However, it must be emphasized that a priori it is not clear in our case 
whether residues from the N terminus are interacting with residues from the 
extracellular loops thereby modulating the effective charge experienced by the 
peptides. This question can only be addressed experimentally with confidence when 
structural studies of the full-length receptor in a functional state become available.  
Unfortunately, not much pharmacological data is available for the entire Y4 
receptor. In case of the human Y1 receptor an Asp residue at the interface between 
TM helix 6 and the third extracellular loop was proposed to contribute largely to 
binding NPY45 in the full-length Y1 receptor. Considering that Asp at this position is 
conserved amongst all Y receptor subtypes it was speculated that this residue 
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generally contributes to binding in all subtypes. Nicole et al. investigated the role of 
this Asp6.59 in more detail46 and verified the proposed interaction of Arg33 or Arg35 
with acidic third extracellular loop (ECL3) residues in the other Y receptor subtypes. 
Our data now indicate that in addition to the above-described interaction additional 
contacts between acidic residues of PP and basic residues of the N-terminal domain of 
the Y4 receptor may contribute to binding. Association of the N-Y4 with PP may be 
therefore not only be of transient nature helping the ligand to be transferred from the 
membrane-bound state into the receptor binding pocket, but may also exist in the 
ligand-bound state, contributing to the high binding affinity and selectivity of PP at 
the Y4 receptor.  
 
 16 
2.4 Conclusions 
 
Based on the data described above, we speculate that the N-terminal domain of 
the Y4 receptor may help in transferring PP from the membrane-bound state into the 
receptor binding pocket (see Fig. 7). As proposed by us in case of ligands of the Y 
receptors43 PP initially associates with the membrane. By binding to the membrane 
the effective concentration in vicinity of the receptor is increased, the search is 
reduced from three to two dimensions, and conformations closer to those of the bound 
state may be induced according to the membrane-compartment model.39; 40 BIACore 
data of PP binding to phospholipid surfaces indicated that binding to membranes is 
moderate.47 Accordingly, an equilibrium is formed, in which PP rapidly diffuses on 
and off the membrane, but mostly remains in vicinity of the membrane. When PP has 
diffused into proximity of the receptor where interactions with the latter can occur it 
may transiently bind to N-Y4 from solution. Whether the complex of PP and N-Y4 
itself will move into vicinity of the extracellular loops, or whether the position of N-
Y4 is fixed by interactions with the membrane or the remaining portion of the 
receptor is presently unclear.  
A scenario, in which N-Y4-bound PP would be transferred into the binding pocket 
by a translational movement of parts of the N-terminal domain is at least compatible 
with the experimental data. These indicate that the binding region for PP is located in 
its central segment, which at the same time is the only part of N-Y4 that is not making 
significant contacts with the membrane surface, and which also possesses sufficient 
internal flexibility to allow the necessary movements. We presently favor a view that 
describes the N-terminal domain as a large flexible loop, anchored onto the membrane 
at the amino terminus via the membrane-associated helix and at the C terminus via the 
first TM. This view is also supported by the recent crystal structures of the b-
adrenergic receptor in which the N-terminal domain is so flexible that electron density 
in this part could not be traced.6; 7 We have now initiated work on constructs that 
include parts of the TM bundle to see whether conformational preferences of N-Y4 
are influenced by the remainder of the receptor. 
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2.5 Materials and Methods 
 
Expression of the N-Y4 sequence as a soluble fusion to ubiquitin resulted in 
heterogeneous fragmentation. In order to prevent in-vivo processing the N-terminal 
domain was fused to the highly insoluble protein ketosteroidisomerase that is encoded 
in the commercial plasmid pET 31b, from which it was liberated by cleavage with the 
TEV protease in mild detergent. 
 
2.5.1 Plasmid Construction, Expression and Purification of N-Y4 
 
The cDNA of the Y4 receptor was obtained from the University of Missouri-Rolla 
(UMR) cDNA Resource Center. The following two primers were used to amplify the 
cDNA corresponding to N-Y4 by PCR. Forward primer: 
GCGCTCGAGGGTTCCGGTTCCGGTTCCGAAAACCTGTACTTCCAGATGA
ACACCTCTCACCTGCTGGC, in which italic letters denote a XhoI cleavage site, 
bold letters denote a Gly-Ser linker sequence and underlined letters identify a TEV 
cleavage sequence; backward primer: 
CTGGCTGAGCTCACATCACGTCCACGGAATCCT with italic letters denoting an 
EspI cleavage site. The amplified PCR product and the target vector, pET 31b  
(Novagen), were simultaneously digested with XhoI and EspI, and ligated into the 
vector with T4 ligase. The construct was confirmed by DNA sequencing (Synergene 
Biotech, Switzerland). All mutants were constructed by site-directed mutagenesis 
using the QuikChange Kit (Stratagene, USA).  
The fusion protein was expressed in inclusion bodies using the BL21(DE3) E.coli 
strain. Protein expression was performed by growing cells at 37°C using minimal 
media containing 15N-NH4Cl as the sole nitrogen source for 15N labeled peptide. 1mM 
IPTG was added to induce protein expression when the OD600 reached 0.8 and cells 
were harvested after 5-6 hours. The fusion protein was purified from inclusion bodies 
in 6M guanidinium hydrochloride by Ni-NTA affinity chromatography. After 
removal of GdnHCl by dialysis the precipitated fusion protein was solubilized in 
50mM Tris pH 8.0 in the presence of 2% N-lauryl sarcosine upon sonication to a final 
concentration of 2mg/ml. The resulting solution was dialyzed against a 20-fold excess 
of 50 mM Tris, pH 8.0 for 4-6 times. The solution was diluted 10 times with 50 mM 
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Tris pH 8.0 and EDTA and DTT were added to a final concentration of 0.5 mM and 1 
mM, respectively. TEV protease was added to a final concentration of 100 mM and 
the cleavage mixture was kept at 4°C over night. The target peptide was purified by 
C18-RP-HPLC (Vydac, USA) and the correctness of the peptide was verified by 
MALDI-TOF MS: 15N labeled N-Y4: 4614 Da (theoretical mass (for 100% labeling): 
4611.1 Da). 
 
2.5.2 Synthesis and Purification of the Neuropeptides and of Unlabelled N-
terminal Fragments 
 
15N-labeled peptides from the NPY family were expressed as soluble fusions to 
Ubiquitin. Ubiquitin was liberated from the neuropeptide using the yeast ubiquitin 
hydrolase, and C-terminal amidation was performed using the a-amidating peptidyl 
glycine amidase (PAM). We have used the protocols for expression, ubiquitin 
cleavage and C-terminal amidation many times before and described in them much 
detail elsewhere, e.g. in Bader et al.33   
Wild-type and mutant N-Y4 peptides and peptides from the NPY family 
containing 15N nuclei at natural abundance were prepared by solid-phase peptide 
synthesis using a robot system (ABI433A, Applied Biosystems). 2-chlorotrityl 
chloride resin preloaded with Fmoc-Met-OH was used to assemble the linear peptide 
using standard Fmoc chemistry (20% piperidine in DMF for Fmoc deprotection, 4 
equiv. HOBt/HBTU for activation, diisopropylethylamine as base, and N-
methylpyrrolidone as solvent). The peptides were cleaved from the resin and 
deprotected with TFA/water/1,2-ethanedithiol/triisopropylsilane 95/2.5/2.5/2.5. The 
product was lyophilized and purified by C18 RP-HPLC and correctness was 
confirmed by ESI-MS: wild-type N-Y4: 4556.8 Da (theoretical mass: 4556.1 Da); 
K13A N-Y4: 4501 Da (theoretical mass: 4499 Da); R20A N-Y4: 4473 Da (theoretical 
mass: 4471 Da); K22A N-Y4: 4501 Da (theoretical mass: 4499 Da). 
In order to synthesize the N-terminally biotinylated forms the peptides were 
mixed with biotin-(PEO)4-NHS-propionate (Molecular Biosciences, USA) in a 1:2 
ratio in 100mM phosphate buffer, pH 7.0 and incubated for 2 hours at RT and 
afterwards purified by C18 RP-HPLC and confirmed by ESI-MS. To confirm that in 
case of E4K-bPP, the biotin was coupled to the N-terminus instead of the side chain 
of lysine, the biotinylated peptide was first digested with pepsin, and subsequently the 
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fragment containing residue 1-16 was analyzed by MALDI-TOF MS-MS. The result 
from this analysis demonstrated that the biotin was exclusively coupled to the N 
terminus. 
 
2.5.3 Dodecylphosphoethanolamine Coupling to the Carboxyl Terminus of N-Y4 
 
The peptide from solid-phase peptide synthesis was cleaved off the resin with 
TFA (0.8 vol %) in DCM with all the protecting groups remaining intact. Following 
removal of solvents the protected peptide was precipitated in cold water, lyophilized 
and redissolved in DMF. The solution was stirred at RT for 5 hours with 3 equivalents 
of dodecylphosphoethanolamine (3 equiv.) in presence of of HATU (1 equiv.), HOAt 
(1 equiv.) and of DIEA(1.5 equiv.). After extraction with a ethyl-acetate:water 
mixture (1:1 v/v) the lipopeptide was deprotected under the same conditions as 
described above. Finally, the lipopeptide was purified by C4 RP-HPLC (Vydac, 
USA), lyophilized and purity higher than 95% was confirmed by MALDI-TOF-MS: 
4848 Da (theoretical mass: 4847.1 Da) and LC-MS. 
 
2.5.4 NMR Experiments  
 
All samples of N-Y4 for structural studies were measured at 1mM concentration, 
40mM d-MES at pH 5.6. For measurements mimicking membrane environments 
300mM d38-DPC or 300mM d25-SDS were added. All experiments were performed at 
700 MHz, 310K using a triple-resonance cryoprobe. Resonance assignments were 
initially performed in the absence of DPC or SDS using [15N,1H]-HSQC, 3D 
[15N,1H]-HSQC-TOCSY (80ms mixing time) and 300ms 3D [15N,1H]-HSQC-NOESY 
experiments. Details of the spectroscopy were similar to those described by us 
earlier.48 Spectra were analyzed using the programs CARA49 and XEASY.50 After 
nearly complete resonance assignments in water were obtained, a 200ms 3D [15N,1H]-
HSQC-NOESY was recorded in the presence of DPC, and the assignments in water  
adjusted to the DPC spectra. Upper distance restraints in DPC or SDS were then 
derived from 50ms 2D NOESY spectra. Internal backbone dynamics were studied by 
measuring a 1H-detected version of a 15N{1H}-NOE experiment. Structures were 
computed based on upper-distance restraints derived from the NOESY spectra using 
the program CYANA51; 52 following the standard simulated annealing protocol. 
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15N{1H}-NOEs were computed from the ratio of integrals from signals in the presence 
to those in the absence of amide proton irradiation.53 Chemical shifts of the 15N,1H-
correlation map in the absence and full assignments in the presence of DPC and SDS 
can be found in the Supp. Mat. Proton chemical shifts were referenced to the water 
line, taken as 4.63 ppm at 310K, from which the nitrogen scale was derived indirectly 
through multiplication with the factor g(15N)/g(1H). 
The coordinates, chemical shift values and heteronucelar NOEs of NY-4 in the 
presence of SDS and DPC have been deposited in the BMRB database under the 
accession number 15708. 
 
2.5.5 Membrane-Association Topology Using Spin Labels 
 
In the spin label studies [15N,1H]-HSQC spectra of 0.5mM solutions of 15N-N-Y4 
containing 300mM DPC were measured in absence and presence of 7mM and 8.8mM 
5-doxyl and 16-doxyl stearic acid, respectively. Signal attenuation was computed 
from the ratio of integrals from peaks in the corresponding spectra. The signal 
attenuation in the presence of the spin label is related to proximity of protons to the 
label. In another set of experiments 0.1mM 15N-labeled N-Y4 was mixed with various 
concentrations of bPP in order to test whether N-Y4 is released from the micelle upon 
interaction with PP. 
 
2.5.6 Surface Plasmon Resonance (SPR) Studies 
 
HBS buffer (10mM HEPES, pH 7.4, 150mM NaCl, 3.4mM EDTA, 0.005% P20) 
was used as the running buffer to achieve physiological pH. N-terminally biotinylated 
neuropeptides were immobilized onto the sensor chip SA (BiaCore, Sweden), which 
contains a streptavidin-coated surface, resulting in about 200 response units (RU) on a 
BIAcore 1000 instrument (BIAcore, Sweden). Different concentrations of N-Y4 
spanning a range of 5 to 100µM were applied to the surface for 30 seconds at a flow-
rate of 20ml/min at 25°C. After each injection of analytes, the flow-cell was flushed 
with regeneration buffer  (1M NaCl, 50mM NaOH) for 30 seconds. Since unspecific 
binding at concentrations higher than 100µM occurred, KD larger than 100µM could 
not be determined precisely. Nevertheless, trends in reduction of binding could still be 
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computed from a limited set of data points, in which values at high concentrations 
were excluded from the analysis. All sensograms were analyzed with the BIA 
evaluation software using a two-state binding model. 
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2.8 Supplementary Materials 
 
Fig. S1: “Snake”-plot type presentation of the human Y4 receptor. The plot was 
downloaded from the GPCR.org website. Note that to enhance clarity not all residues 
from the N-terminal domain and the long loops are shown 
 
 
 
 
 
 
 
Fig. S2: Summary of the meaningful distance restraints as derived from the 
unambiguously assigned inter-residue NOEs between backbone HN,Hα and Hβ of N-
Y4 bound to DPC micelles.  
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Fig. S3: Expansion of the 100ms NOESY displaying the region involving NOEs 
between sequential amide protons (DPC micelles) 
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Table S4: Chemical shifts for N-Y4 bound to DPC micelles a referenced to the signal 
of residual HDO at 4.63 ppm 
 
Residue HN H'a Hb others 
Met 1 - 4.07 -, - gCH2 -, -; eCH3 - 
Asn 2 8.99 4.92 2.92, 2.80 dNH2 7.66, 6.90 
Thr 3 8.63 3.89 4.20 gCH3 1.20; gOH - 
Ser 4 8.43 4.14 3.91, 3.91 gOH - 
His 5 8.11 4.50 3.25, 3.25 dNH -; d2H 6.89; eH 7.66; e2NH - 
Leu 6 7.69 3.98 1.74, 1.74 gH 1.67; dCH3 0.90, 0.84 
Leu 7 8.01 3.91 1.75, 1.75 gH 1.58; dCH3 0.85, 0.85 
Ala 8 7.52 4.03 1.44  
Leu 9 7.40 4.09 1.89, 1.89 gH 1.47; dCH3 0.83, 0.83 
Leu 10 7.43 4.20 1.72, 1.72 gH 1.55; dCH3 0.83, 0.79 
Leu 11 7.50 4.51 1.65, 1.65 gH 1.50; dCH3 0.87, 0.87 
Pro 12  - 2.29, 1.86 gCH2 1.98, 1.98; dCH2 3.54, 3.69 
Lys 13 8.35 4.30 1.70, 1.70 gCH2 1.42, 1.42; dCH2 1.78, 1.78; eCH2 
2.96, 2.96; zNH3  - 
Ser 14 8.30 4.68 3.81, 3.81 gOH - 
Pro 15  4.40 2.24, 1.88 gCH2 1.97, 1.97; dCH2 3.69, 3.79 
Gln 16 8.37 4.27 2.08, 1.94 gCH2 2.33, 2.33; eNH2 7.45, 6.78 
Gly 17 8.27 3.90, 3.90   
Glu 18 8.22 4.26 2.01, 1.88 gCH2 2.24, 2.24; eH - 
Asn 19 8.45 4.64 2.79, 2.71 dNH2 7.53, 6.86 
Arg 20 8.26 4.31 1.85, 1.71 gCH2 1.58, 1.58; dCH2 3.14, 3.14; eNH -; 
hNH2 -, - 
Ser 21 8.22 4.37 3.80, 3.80 gOH - 
Lys 22 8.10 4.57 1.65, 1.65 gCH2 1.76, 1.76; dCH2 1.41, 1.41; eCH2 
2.95, 2.95; zNH3  - 
Pro 23  4.40 2.27, 2.27 gCH2 1.98, 1.98; dCH2 3.55, 3.55 
Leu 24 8.34 4.26 1.63, 1.63 gH 1.55; dCH3 0.86, 0.86 
Gly 25 8.27 3.92, 3.92   
Thr 26 7.94 4.53 4.08 gCH3 1.15; gOH - 
Pro 27  - 2.47, 2.14 gCH2 1.96, 1.82; dCH2 3.75, 3.57 
Tyr 28 7.91 4.34 2.79, 2.79 dH 6.92, 6.92; eH 6.71, 6.71; hOH - 
Asn 29 8.08 4.61 2.71, 2.59 dNH2 7.48, 6.79 
Phe 30 8.21 4.44 3.13, 3.05 dH 7.24, 7.24; eH 7.14, 7.14; zH - 
Ser 31 8.07 4.39 3.81, 3.81 gOH - 
Glu 32 8.08 4.16 1.94, 1.85 gCH2 2.21, 2.21; eH - 
His 33 8.24 4.59 3.28, 3.09 dNH -; d2H -; eH -;   NH - 
Cys 34 8.20 4.39 2.86, 2.86  SH - 
Gln 35 8.43 4.25 2.08, 1.96  CH  2.31, 2.31;  NH  7.43, 6.76 
Asp 36 8.25 4.64 2.76, 2.64  H - 
Ser 37 8.13 4.42 3.80, 3.80  OH - 
Val 38 8.01 4.11 2.06  CH  0.86, 0.86 
Asp 39 8.27 4.26 2.74, 2.60  H - 
Val 40 7.94 4.09 2.09  CH  0.87, 0.87 
Met 41 7.87 4.26 1.94, 1.94  CH  -, -;  CH  2.04 
a 1mM in 300mM DPC / 90% H2O/10% 2H2O at 310 K ,  20mM MES and pH 5.6 
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Table S5: 1HN and 15N chemical shifts of N-Y4 in water in the presence and absence 
of DPC micelles. 
Res. δ(1H) [ppm] δ(15N) [ppm] δ(
1H) [ppm] 
DPC 
δ(15N) [ppm] 
DPC 
M1 - - - - 
N2 - - - - 
T3 8.171 119.838 8.637 116.741 
S4 8.290 114.787 8.413 117.173 
H5 8.260 127.348 - - 
L6 - - 7.652 118.535 
L7 8.006 121.818 8.000 116.495 
A8 7.953 123.247 7.521 118.535 
L9 7.817 119.790 7.395 115.914 
L10 7.915 121.832 7.422 115.509 
L11 7.897 123.675 7.494 117.061 
P12 - - - - 
K13 8.257 120.984 8.350 120.579 
S14 8.221 117.544 8.319 118.053 
P15 - - - - 
Q16 8.338 119.671 8.355 119.671 
G17 8.243 109.457 8.255 109.367 
E18 8.225 120.207 8.232 120.105 
N19 8.454 119.731 8.449 119.615 
R20 8.252 121.321 8.247 121.173 
S21 8.211 116.370 8.214 116.299 
K22 8.092 123.461 8.095 123.333 
P23 - - - - 
L24 8.423 122.478 8.319 121.952 
G25 8.315 109.153 8.286 108.684 
T26 7.874 115.514 7.910 115.127 
P27 - - - - 
Y28 - - 7.886 118.731 
N29 8.083 120.162 8.045 119.607 
F30 7.989 120.843 8.083 120.695 
S31 8.069 116.045 8.084 115.520 
E32 8.133 121.685 8.162 121.566 
H33 8.288 117.461 8.332 117.816 
C34 - - - - 
Q35 8.430 121.020 8.460 121.068 
D36 8.224 120.984 8.289 121.269 
S37 8.096 115.276 8.123 115.324 
V38 8.002 120.362 8.008 120.111 
D39 8.251 122.983 8.247 122.843 
V40 7.918 119.379 7.925 119.118 
M41 7.850 128.423 7.831 127.626 
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Fig. S6: Summary of the meaningful distance restraints as derived from the 
unambiguously assigned inter-residue NOEs between backbone HN,Hα and Hβ of N-
Y4 bound to SDS micelles.  
 
 
 
 
Fig. S7: Comparison of [15N,1H]-HSQC data of N-Y4 in the presence of DPC  (left) 
or SDS (right) micelles: 
 
 
 
 
Fig. S8: Comparison of 15N{1H}-NOE data of N-Y4 in the presence of DPC  (red 
diamonds) or SDS (black circles) micelles: 
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Fig. S9: Left: Residual signal intensity of cross peaks in the [15N,1H]-HSQC in the 
presence of 5-doxylstearate relative to those in the absence of the spinlabel. Right: 
Free energies of transfer for whole amino acids from bulk aqueous solution into the 
water-membrane interface. Values were taken from Wimley et al.[36] 
 
 
 
 
 
 
 
Fig. S10: Left: Overlay of NOESY spectra of N-Y4 with the construct containing the 
C-terminal lipid attachment (green) (all spectra recorded in the presence of DPC 
micelles). Right: Expansion showing the assignment of the helical segment of N-Y4. 
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Table S11: Chemical shifts for N-Y4 bound to SDS micellesa referenced to the 
signal of residual HDO at 4.63 ppm 
 
Residue HN H'  H  Others 
Met 1 - 4.19 2.19  CH 2.55;  CH  2.19 
Asn 2  8.66 4.98 2.98 , 2.79  NH  7.57, 6.86 
Thr 3 8.28 4.26 4.04  CH  1.22;  OH - 
Ser 4 8.28 4.23 3.92  OH - 
His 5 8.06 4.57 3.3  NH -;   H 7.34;  H 8.64;   NH - 
Leu 6 7.84 3.99 1.69, 1.78  H 1.57;  CH  0.87, 0.94 
Leu 7 8.03 3.95 1.57, 1.78  H 1.58;  CH  0.87, 0.93 
Ala 8 7.52 4.05 1.47  
Leu 9 7.47 4.14 1.70, 1.87  H 1.54;  CH  0.86, 0.93 
Leu 10 7.59 4.22 1.75, 1.80  H 1.55;  CH  0.82, 0.86 
Leu 11 7.65 4.37 1.77  H 1.56;  CH  0.90, 0.94 
Pro 12  4.45 2.35, 2.05  CH  2.0,  CH  3.54, 3.77 
Lys 13 7.90 4.44 1.81  CH  1.46;  CH  1.63 ;  CH  - ;  NH  
6.96 
Ser 14 7.95 3.88 3.80  OH - 
Pro 15  4.46 2.31, 1.99  CH  2.06;  CH  3.80, 3.75  
Gln 16 8.30 4.31 2.15, 1.97  CH  2.30, 2.37;  NH  7.42, 6.72 
Gly 17 8.18 3.93   
Glu 18 8.14 4.30 2.08, 1.94  CH  2.33;  H - 
Asn 19 8.30 4.71 2.84, 2.71  NH  7.49, 6.83 
Arg 20 8.0 4.35 1.86, 1.78  CH  1.64;  CH  3.20;  NH 7.2;  NH  - 
Ser 21 8.22 4.43 3.83  OH - 
Lys 22 7.99 4.35  1.87  CH  1.45;  CH  1.75 ;  CH -;  NH  - 
Pro 23  4.44 2.30, 1.98  CH  1.91;  CH  3.77, 3.68 
Leu 24 8.03 4.34 1.72, 1.68  H 1.58;  CH  0.94, 0.89 
Gly 25 7.98 4.00, 3.91   
Thr 26 7.82 4.61 4.17  CH  1.21;  OH - 
Pro 27   4.39 2.17  CH  2.17;  CH   3.58 
Tyr 28 7.61 4.34 2.71, 2.67  H 6.88;  H 6.71;  OH - 
Asn 29 7.93 4.68 2.80, 2.63  NH  7.42, 6.76 
Phe 30 8.08 4.43 3.20, 3.07  H 7.28;  H 7.21;  H 7.07 
Ser 31 8.18 4.31 3.93, 3.92  OH - 
Glu 32 7.85 4.23 2.03, 1.91  CH  2.23;  H - 
His 33 8.12 4.62 3.34, 3.20  NH -;   H7.31;  H -;   NH - 
Cys 34 8.15 4.66 3.22, 2.98  SH - 
Gln 35 8.24 4.33 2.11, 1.98  CH  2.34;  NH  7.41, 6.75 
Asp 36 8.31 4.65 2.75, 2.69  H - 
Ser 37 8.18 4.45 3.85  OH - 
Val 38 8.00 4.14 2.09  CH  0.89, 0.85 
Asp 39 8.30 4.62  2.60  H - 
Val 40 7.94 4.12 2.09  CH  0.90 
Met 41 7.89 4.34 1.92  CH  2.34;  CH  - 
                a1mM in 300mM SDS / 90% H2O/10% 2H2O at 310 K, 20mM MES and pH 5.6 
 
 33 
Selective N-terminal biotinylation: Proof by MS-MS 
A P L K P E Y P G D N A T P E QMA Q Y A A E L R R Y I N M L T R P R Y-NH2 
MW=4224.8 Da 
Biotin-(PEO)4-NHS-propionate (NHS-(PEO)4-Biotin): MW=588.67 Da, mass added 
to the target: 474.6.Da 
Pepsin was used to digest the biotinylated peptide yielding a fragment corresponding 
to biotinylated 1-16 N-Y4. TOF-TOF MS was utilized to analyze this fragment:  
 
 
The non-biotinylated sample served as a control, and the TOF-TOF result is as 
follows: 
 
 
 
 y3 y4 y5 y6 y7 y8 y9 y10 y11 y12 y13 y14 y15 y16 
Expected 372.3 473.4 544.5 658.6 773.7 830.8 927.9 1091.1 1220 1317.3 1445.5 1558.6 1655.7 1726.8 
Observed  373.4 474.5 544.5 659.5 774.4  928.8 1091.9  1317.8 1445.8  1656.1 1726.9 
 
Almost all expected ions from the digest are observed.  Thereafter, the biotinylated 
sample was fragmented under the same conditions, and the TOF-TOF MS spectrum is 
depicted below: 
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If we assume that biotin was coupled to the N terminus, the following expected y ions 
as listed 
 
 y4 y5 y6 y7 y8 y9 y10 y11 y12 y13 y14 y15 y16 
Expected1 473.4 544.5 658.6 773.7 830.8 927.9 1091.1 1220 1317.3 1445.5 1558.6 1655.7 2201.1 
Expected2 473.4 544.5 658.6 773.7 830.8 927.9 1091.1 1220 1317.3 1920.1 2033.2 2130.3 2201.1 
Observed  474.6 545.6 659.8   928.9 1091.8  1317.7 1445.8 1558.9 1656.1 2200.1 
Expected1: expected y ions if biotin was coupled to the N terminus 
Expected2: expected y ions if biotin was coupled to lysine 
 
The observed and expected y ions have been summarized in the table above. It is 
evident that the observed y ions, in particular y ions 13-16 correspond to those where 
biotin was coupled to the N terminus. In addition b1 ions 545.6 can be identified 
corresponding to biotinylated N terminus residue (MW of biotinilyated Alanine b 
ion=546.0). None of the fragments occurring only for Lys-biotinylated peptide was 
observed. 
 
 
